Global Complement Drug for Kidney Disease Production, Demand and Key Producers, 2022-2028

October 2022 | 97 pages | ID: G198BA0C394FEN
GlobalInfoResearch

Abstracts

This report studies the global Complement Drug for Kidney Disease demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Complement Drug for Kidney Disease, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Complement Drug for Kidney Disease that contribute to its increasing demand across many markets.

The global Complement Drug for Kidney Disease market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).

Highlights and key features of the study

Global Complement Drug for Kidney Disease total market, 2017-2028, (USD Million)

Global Complement Drug for Kidney Disease total market by region & country, CAGR, 2017-2028, (USD Million)

U.S. VS China: Complement Drug for Kidney Disease total market, key domestic companies and share, (USD Million)

Global Complement Drug for Kidney Disease revenue by player and market share 2017-2022, (USD Million)

Global Complement Drug for Kidney Disease total market by Type, CAGR, 2017-2028, (USD Million)

Global Complement Drug for Kidney Disease total market by Application, CAGR, 2017-2028, (USD Million)

This reports profiles major players in the global Complement Drug for Kidney Disease market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amyndas, Apellis, Alexion, Novartis and Omeros, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Complement Drug for Kidney Disease market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.

Global Complement Drug for Kidney Disease Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Complement Drug for Kidney Disease Market, Segmentation by Type

• Peptides
• Antibodies
• Others

Global Complement Drug for Kidney Disease Market, Segmentation by Application

• Hospital
• Clinic
• Others

Companies Profiled:

• Amyndas
• Apellis
• Alexion
• Novartis
• Omeros

Key Questions Answered

1. How big is the global Complement Drug for Kidney Disease market?

2. What is the demand of the global Complement Drug for Kidney Disease market?

3. What is the year over year growth of the global Complement Drug for Kidney Disease market?

4. What is the total value of the global Complement Drug for Kidney Disease market?

5. Who are the major players in the global Complement Drug for Kidney Disease market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 Complement Drug for Kidney Disease Introduction
1.2 World Complement Drug for Kidney Disease Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Complement Drug for Kidney Disease Total Market by Region
  1.3.1 World Complement Drug for Kidney Disease Market Size by Region (2017-2028)
  1.3.2 United States Complement Drug for Kidney Disease Market Size (2017-2028)
  1.3.3 China Complement Drug for Kidney Disease Market Size (2017-2028)
  1.3.4 Europe Complement Drug for Kidney Disease Market Size (2017-2028)
  1.3.5 Japan Complement Drug for Kidney Disease Market Size (2017-2028)
  1.3.6 South Korea Complement Drug for Kidney Disease Market Size (2017-2028)
  1.3.7 ASEAN Complement Drug for Kidney Disease Market Size (2017-2028)
  1.3.8 India Complement Drug for Kidney Disease Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Complement Drug for Kidney Disease Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Complement Drug for Kidney Disease Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 WORLD COMPLEMENT DRUG FOR KIDNEY DISEASE COMPANIES COMPETITIVE ANALYSIS

2.1 World Complement Drug for Kidney Disease Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
  2.2.1 Global Complement Drug for Kidney Disease Industry Rank of Major Players
  2.2.2 Global Concentration Ratios (CR4) for Complement Drug for Kidney Disease in 2021
  2.2.3 Global Concentration Ratios (CR8) for Complement Drug for Kidney Disease in 2021
2.3 Complement Drug for Kidney Disease Company Evaluation Quadrant
2.4 Complement Drug for Kidney Disease Market: Overall Company Footprint Analysis
  2.4.1 Complement Drug for Kidney Disease Market: Region Footprint
  2.4.2 Complement Drug for Kidney Disease Market: Company Product Type Footprint
  2.4.3 Complement Drug for Kidney Disease Market: Company Product Application Footprint
2.5 Competitive Environment
  2.5.1 Historical Structure of the Industry
  2.5.2 Barriers of Market Entry
  2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity

3 UNITED STATES VS CHINA VS REST OF THE WORLD

3.1 United States VS China: Complement Drug for Kidney Disease Market Comparison
  3.1.1 United States VS China: Complement Drug for Kidney Disease Market Size Comparison (2017 & 2021 & 2028)
  3.1.2 United States VS China: Complement Drug for Kidney Disease Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Complement Drug for Kidney Disease Major Players and Market Share, 2017-2022
  3.2.1 Major Players of Complement Drug for Kidney Disease in United States, Headquarters (States, Country)
  3.2.2 United States Complement Drug for Kidney Disease Revenue by Domestic Player, (2017-2022)
3.3 China Complement Drug for Kidney Disease Major Players and Market Share, 2017-2022
  3.3.1 Major Players of Complement Drug for Kidney Disease in China, Headquarters (Province, Country)
  3.3.2 China Complement Drug for Kidney Disease Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Complement Drug for Kidney Disease Major Players and Market Share, 2017-2022
  3.4.1 Major Players of Complement Drug for Kidney Disease in Rest of World, Headquarters (State, Country)
  3.4.2 Rest of World Complement Drug for Kidney Disease Revenue by Domestic Player, (2017-2022)

4 MARKET ANALYSIS BY TYPE

4.1 World Complement Drug for Kidney Disease Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
  4.2.1 Peptides
  4.2.2 Antibodies
  4.2.3 Others
4.3 Market Segment by Type
  4.3.1 World Complement Drug for Kidney Disease Market Size by Type (2017-2022)
  4.3.2 World Complement Drug for Kidney Disease Market Size by Type (2023-2028)
  4.3.3 World Complement Drug for Kidney Disease Market Size Market Share by Type (2017-2028)

5 MARKET ANALYSIS BY APPLICATION

5.1 World Complement Drug for Kidney Disease Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
  5.2.1 Hospital
  5.2.2 Clinic
  5.2.3 Others
5.3 Market Segment by Application
  5.3.1 World Complement Drug for Kidney Disease Market Size by Application (2017-2022)
  5.3.2 World Complement Drug for Kidney Disease Market Size by Application (2023-2028)
  5.3.3 World Complement Drug for Kidney Disease Market Size by Application (2017-2028)

6 COMPANY PROFILES

6.1 Amyndas
  6.1.1 Amyndas Details
  6.1.2 Amyndas Major Business
  6.1.3 Amyndas Complement Drug for Kidney Disease Product and Services
  6.1.4 Amyndas Complement Drug for Kidney Disease Revenue, Gross Margin and Market Share (2017-2022)
  6.1.5 Amyndas Recent Developments/Updates
  6.1.6 Amyndas Competitive Strengths & Weaknesses
6.2 Apellis
  6.2.1 Apellis Details
  6.2.2 Apellis Major Business
  6.2.3 Apellis Complement Drug for Kidney Disease Product and Services
  6.2.4 Apellis Complement Drug for Kidney Disease Revenue, Gross Margin and Market Share (2017-2022)
  6.2.5 Apellis Recent Developments/Updates
  6.2.6 Apellis Competitive Strengths & Weaknesses
6.3 Alexion
  6.3.1 Alexion Details
  6.3.2 Alexion Major Business
  6.3.3 Alexion Complement Drug for Kidney Disease Product and Services
  6.3.4 Alexion Complement Drug for Kidney Disease Revenue, Gross Margin and Market Share (2017-2022)
  6.3.5 Alexion Recent Developments/Updates
  6.3.6 Alexion Competitive Strengths & Weaknesses
6.4 Novartis
  6.4.1 Novartis Details
  6.4.2 Novartis Major Business
  6.4.3 Novartis Complement Drug for Kidney Disease Product and Services
  6.4.4 Novartis Complement Drug for Kidney Disease Revenue, Gross Margin and Market Share (2017-2022)
  6.4.5 Novartis Recent Developments/Updates
  6.4.6 Novartis Competitive Strengths & Weaknesses
6.5 Omeros
  6.5.1 Omeros Details
  6.5.2 Omeros Major Business
  6.5.3 Omeros Complement Drug for Kidney Disease Product and Services
  6.5.4 Omeros Complement Drug for Kidney Disease Revenue, Gross Margin and Market Share (2017-2022)
  6.5.5 Omeros Recent Developments/Updates
  6.5.6 Omeros Competitive Strengths & Weaknesses

7 RAW MATERIAL AND INDUSTRY CHAIN

7.1 Raw Material of Complement Drug for Kidney Disease and Key Manufacturers
7.2 Complement Drug for Kidney Disease Manufacturing Costs
7.3 Complement Drug for Kidney Disease Production Process
7.4 Complement Drug for Kidney Disease Industrial Chain

8 DISTRIBUTION CHANNEL ANALYSIS

8.1 Distribution Channel Breakdown for Complement Drug for Kidney Disease Shipments (%): 2017-2028
  8.1.1 Direct Channel
  8.1.2 Indirect Channel
8.2 Complement Drug for Kidney Disease Typical Distributors
8.3 Complement Drug for Kidney Disease Typical Customers

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Complement Drug for Kidney Disease Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Complement Drug for Kidney Disease Market Size by Region (2017-2022) & (USD Million)
Table 3. World Complement Drug for Kidney Disease Market Size by Region (2023-2028) & (USD Million)
Table 4. World Complement Drug for Kidney Disease Market Size Market Share by Region (2017-2022)
Table 5. World Complement Drug for Kidney Disease Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Complement Drug for Kidney Disease Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Complement Drug for Kidney Disease Players in 2021
Table 9. World Complement Drug for Kidney Disease Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Complement Drug for Kidney Disease Company Evaluation Quadrant
Table 11. Head Office of Key Complement Drug for Kidney Disease Player
Table 12. Complement Drug for Kidney Disease Market: Company Product Type Footprint
Table 13. Complement Drug for Kidney Disease Market: Company Product Application Footprint
Table 14. Complement Drug for Kidney Disease Mergers & Acquisitions Activity
Table 15. United States VS China Complement Drug for Kidney Disease Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Complement Drug for Kidney Disease in United States, Headquarters (States, Country)
Table 17. United States Complement Drug for Kidney Disease Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Complement Drug for Kidney Disease Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Complement Drug for Kidney Disease in China, Company Headquarters (Province, Country)
Table 20. China Complement Drug for Kidney Disease Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Complement Drug for Kidney Disease Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Complement Drug for Kidney Disease in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Complement Drug for Kidney Disease Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Complement Drug for Kidney Disease Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Complement Drug for Kidney Disease Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Complement Drug for Kidney Disease Revenue by Type (2017-2022) & (USD Million)
Table 27. World Complement Drug for Kidney Disease Revenue by Type (2023-2028) & (USD Million)
Table 28. World Complement Drug for Kidney Disease Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Complement Drug for Kidney Disease Revenue by Application (2017-2022) & (USD Million)
Table 30. World Complement Drug for Kidney Disease Revenue by Application (2023-2028) & (USD Million)
Table 31. Amyndas Basic Information, Manufacturing Base and Competitors
Table 32. Amyndas Major Business
Table 33. Amyndas Complement Drug for Kidney Disease Product and Services
Table 34. Amyndas Complement Drug for Kidney Disease Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Amyndas Recent Developments/Updates
Table 36. Amyndas Competitive Strengths & Weaknesses
Table 37. Apellis Basic Information, Manufacturing Base and Competitors
Table 38. Apellis Major Business
Table 39. Apellis Complement Drug for Kidney Disease Product and Services
Table 40. Apellis Complement Drug for Kidney Disease Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Apellis Recent Developments/Updates
Table 42. Apellis Competitive Strengths & Weaknesses
Table 43. Alexion Basic Information, Manufacturing Base and Competitors
Table 44. Alexion Major Business
Table 45. Alexion Complement Drug for Kidney Disease Product and Services
Table 46. Alexion Complement Drug for Kidney Disease Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. Alexion Recent Developments/Updates
Table 48. Alexion Competitive Strengths & Weaknesses
Table 49. Novartis Basic Information, Manufacturing Base and Competitors
Table 50. Novartis Major Business
Table 51. Novartis Complement Drug for Kidney Disease Product and Services
Table 52. Novartis Complement Drug for Kidney Disease Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Novartis Recent Developments/Updates
Table 54. Omeros Basic Information, Manufacturing Base and Competitors
Table 55. Omeros Major Business
Table 56. Omeros Complement Drug for Kidney Disease Product and Services
Table 57. Omeros Complement Drug for Kidney Disease Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 58. Complement Drug for Kidney Disease Raw Material
Table 59. Key Manufacturers of Complement Drug for Kidney Disease Raw Materials
Table 60. Complement Drug for Kidney Disease Typical Distributors
Table 61. Complement Drug for Kidney Disease Typical Customers

List Of Figures

LIST OF FIGURES

Figure 1. Complement Drug for Kidney Disease Picture
Figure 2. World Complement Drug for Kidney Disease Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Complement Drug for Kidney Disease Total Market Size (2017-2028) & (USD Million)
Figure 4. World Complement Drug for Kidney Disease Market Size Market Share by Region (2017-2028)
Figure 5. United States Complement Drug for Kidney Disease Market Size (2017-2028) & (USD Million)
Figure 6. China Complement Drug for Kidney Disease Market Size (2017-2028) & (USD Million)
Figure 7. Europe Complement Drug for Kidney Disease Market Size (2017-2028) & (USD Million)
Figure 8. Japan Complement Drug for Kidney Disease Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Complement Drug for Kidney Disease Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Complement Drug for Kidney Disease Market Size (2017-2028) & (USD Million)
Figure 11. India Complement Drug for Kidney Disease Market Size (2017-2028) & (USD Million)
Figure 12. Complement Drug for Kidney Disease Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Complement Drug for Kidney Disease by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Complement Drug for Kidney Disease Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Complement Drug for Kidney Disease Markets in 2021
Figure 17. United States VS China: Complement Drug for Kidney Disease Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Complement Drug for Kidney Disease Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Complement Drug for Kidney Disease Market Size Market Share by Type in 2021
Figure 20. Peptides
Figure 21. Antibodies
Figure 22. Others
Figure 23. World Complement Drug for Kidney Disease Market Size Market Share by Type (2017-2028)
Figure 24. World Complement Drug for Kidney Disease Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 25. World Complement Drug for Kidney Disease Market Size Market Share by Application in 2021
Figure 26. Hospital
Figure 27. Clinic
Figure 28. Others
Figure 29. World Complement Drug for Kidney Disease Market Size Market Share by Application (2017-2028)
Figure 30. Manufacturing Cost Structure Analysis of Complement Drug for Kidney Disease in 2021
Figure 31. Manufacturing Process Analysis of Complement Drug for Kidney Disease
Figure 32. Complement Drug for Kidney Disease Industrial Chain
Figure 33. Distribution Channel Breakdown for Complement Drug for Kidney Disease Shipments (%): 2017-2028
Figure 34. Direct Channel Pros & Cons
Figure 35. Indirect Channel Pros & Cons
Figure 36. Methodology
Figure 37. Research Process and Data Source